Publikationen Zentrum für endokrine Tumore (ZET)

Kimpel O, Schindler P, Schmidt-Pennington L, Altieri B, Megerle F, Haak H, Pittaway J, Dischinger U, Quinkler M, Mai K, Kroiss M, Polat B, Fassnacht M (2023)
Efficacy and safety of radiation therapy in advanced adrenocortical carcinoma.
British Journal of Cancer 2023 Feb; 128(4): 586-593 
Zur Publikation

Werner RA, Sayehli C, Hänscheid H, Higuchi T, Serfling SE, Fassnacht M, Goebeler ME, Buck AK, Kroiss M (2023)
Successful combination of selpercatinib and radioiodine after pretherapeutic dose estimation in RET-altered thyroid carcinoma.
European Journal of Nuclear Medicine and Molecular Imaging 2023 May; 50(6): 1833-1834
Zur Publikation

Hahner S, Hartrampf PE, Mihatsch PW, Nauerz M, Heinze B, Hänscheid H, Fuß CT, Werner RA, Pamporaki C, Kroiss M, Fassnacht M, Buck AK, Schirbel A (2022) Targeting 11-beta hydroxylase with [ 131I]IMAZA - a novel approach for the treatment of advanced adrenocortical carcinoma.
The Journal of Clinical Endocrinology & Metabolism Mar 24; 107(4): e1348-e1355
Zur Publikation

Jouinot A, Lippert J, Sibony M, Violon F, Jeanpierre L, De Murat D, Armignacco R, Septier A, Perlemoine K, Letourneur F, Izac B, Ragazzon B, Leroy K, Pasmant E, North MO, Gaujoux S, Dousset B, Groussin L, Libe R, Terris B, Fassnacht M, Ronchi CL, Bertherat J, Assie G (2022)
Transcriptome in paraffin samples for the diagnosis and prognosis of adrenocortical carcinoma.
European Journal of Endocrinology 2022 Apr 21; 186(6): 607-617
Zur Publikation

Lenschow C, Schrägle S, Kircher S, Lorenz K, Machens A, Dralle H, Riss P, Scheuba C, Pfestroff A, Spitzweg C, Zielke A, Nießen A, Dotzenrath C, Riemann B, Quinkler M, Vorländer C, Zahn A, Raue F, Chiapponi C, Iwen KA, Steinmüller T, Kroiss M, Schlegel N (2022)
Clinical Presentation, Treatment, and Outcome of Parathyroid Carcinoma: Results of the NEKAR Retrospective International Multicenter Study. NEKAR study group.
Annals of Surgery 2022 Feb 1; 275(2): e479-e487.
Zur Publikation

Lippert J, Altieri B, Morrison B, Steinhauer S, Smith G, Lorey A, Urlaub H, Kircher S, Sitch A, Fassnacht M, Ronchi CL (2022)
Prognostic Role of Targeted Methylation Analysis in Paraffin-embedded Samples of Adrenocortical Carcinoma.
The Journal of Clinical Endocrinology & Metabolism 2022 Sep 28; 107(10): 2892-2899. 
Zur Publikation

Riedmeier M, Decarolis B, Haubitz I, Reibetanz J, Wiegering A, Härtel C, Schlegel PG, Fassnacht M, Wiegering V (2022)
Assessment of prognostic factors in pediatric adrenocortical tumors: A systematic review and evaluation of a modified S-GRAS-Score.
European Journal of Endocrinology 2022 Oct 26; 187(6): 751-763
Zur Publikation

Serfling SE, Zhi Y, Megerle F, Fassnacht M, Buck AK, Lapa C, Werner RA (2022)
Somatostatin receptor-directed molecular imaging for therapeutic decision-making in patients with medullary thyroid carcinoma.
Endocrine 2022 Oct; 78(1): 169-176 
Zur Publikation

Terzolo M, Fassnacht M (2022)
ENDOCRINE TUMOURS: Our experience with the management of patients with non-metastatic adrenocortical carcinoma.
European Journal of Endocrinology 2022 Jul 19; 187(3): R27-R40 
Zur Publikation

Wiegering V, Riedmeier M, Thompson LDR, Virgone C, Redlich A, Kuhlen M, Gultekin M, Yalcin B, Decarolis B, Härtel C, Schlegel PG, Fassnacht M, Timmermann B (2022)
Radiotherapy for pediatric adrenocortical carcinoma – Review of the literature.
Clinical and Translational Radiation Oncolology 2022 May 14; 35:56-63
Zur Publikation

Adam P, Kircher S, Sbiera I, Koehler VF, Berg E, Knösel T, Sandner B, Fenske WK, Bläker H, Smaxwil C, Zielke A, Sipos B, Allelein S, Schott M, Dierks C, Spitzweg C, Fassnacht M, Kroiss M (2021)
FGF-Receptors and PD-L1 in Anaplastic and Poorly Differentiated Thyroid Cancer: Evaluation of the Preclinical Rationale.
Frontiers in Endocrinology (Lausanne) 2021 Aug 12; 12:712107
Zur Publikation

Amar L, Pacak K, Steichen O, Akker SA, Aylwin SJB, Baudin E, Buffet A, Burnichon N, Clifton-Bligh RJ, Dahia PLM, Fassnacht M, Grossman AB, Herman P, Hicks RJ, Januszewicz A, Jimenez C, Kunst HPM, Lewis D, Mannelli M, Naruse M, Robledo M, Taïeb D, Taylor DR, Timmers HJLM, Treglia G, Tufton N, Young WF, Lenders JWM, Gimenez-Roqueplo AP, Lussey-Lepoutre C (2021)
International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers.
Nature Reviews Endocrinology 2021 Jul; 17(7): 435-444
Zur Publikation

Basile V, Puglisi S, Altieri B, Canu L, Libè R, Ceccato F, Beuschlein F, Quinkler M, Calabrese A, Perotti P, Berchialla P, Dischinger U, Megerle F, Baudin E, Bourdeau I, Lacroix A, Loli P, Berruti A, Kastelan D, Haak HR, Fassnacht M, Terzolo M (2021)
What Is the Optimal Duration of Adjuvant Mitotane Therapy in Adrenocortical Carcinoma? An Unanswered Question.
Journal of Personalized Medicine 2021 Apr 4; 11(4): 269
Zur Publikation

Bliziotis NG, Kluijtmans LAJ, Soto S, Tinnevelt GH, Langton K, Robledo M, Pamporaki C, Engelke UFH, Erlic Z, Engel J, Deutschbein T, Nölting S, Prejbisz A, Richter S, Prehn C, Adamski J, Januszewicz A, Reincke M, Fassnacht M, Eisenhofer G, Beuschlein F, Kroiss M, Wevers RA, Jansen JJ, Deinum J, Timmers HJLM (2021)
Pre- versus post-operative untargeted plasma nuclear magnetic resonance spectroscopy metabolomics of pheochromocytoma and paraganglioma.
Endocrine 2021 Sep 18; 75: 254–265
Zur Publikation

Bothou C, Sharma A, Oo A, Kim B, Perge P, Igaz P, Ronchi CL, Shapiro I, Hantel C (2021)
Novel Insights into the Molecular Regulation of Ribonucleotide Reductase in Adrenocortical Carcinoma Treatment.
Cancers (Basel) 2021 Aug 20; 13(16): 4200
Zur Publikation

Crona J, Baudin E, Terzolo M, Chrisoulidou A, Angelousi A, Ronchi CL, Oliveira CL, Nieveen van Dijkum EJM, Ceccato F, Borson-Chazot F, Reimondo G, Tiberi GAM, Ettaieb H, Kiriakopoulos A, Canu L, Kastelan D, Osher E, Yiannakopoulou E, Arnaldi G, Assié G, Paiva I, Bourdeau I, Newell-Price J, Nowak KM, Romero MT, De Martino MC, Bugalho MJ, Sherlock M, Vantyghem MC, Dennedy MC, Loli P, Rodien P, Feelders R, de Krijger R, Van Slycke S, Aylwin S, Morelli V, Vroonen L, Shafigullina Z, Bancos I, Trofimiuk-Müldner M, Quinkler M, Luconi M, Kroiss M, Naruse M, Igaz P, Mihai R, Della Casa S, Berruti A, Fassnacht M, Beuschlein F (2021)
ENSAT registry-based randomized clinical trials for adrenocortical carcinoma.
European Journal of Endocrinology 2021 Feb; 184(2): R51-R59
Zur Publikation

Detomas M, Altieri B, Schlötelburg W, Appenzeller S, Schlaffer S, Coras R, Schirbel A, Wild V, Kroiss M, Sbiera S, Fassnacht M, Deutschbein T (2021)
Case Report: Consecutive Adrenal Cushing's Syndrome and Cushing's Disease in a Patient With Somatic CTNNB1, USP8, and NR3C1 Mutations.
Frontiers in Endocrinology (Lausanne) 2021 Aug 20; 12: 731579
Zur Publikation

Deutschbein T, Jaursch-Hancke C, Knappe UJ, Saeger W, Flitsch J, Bojunga J, Buchfelder M, Ditzen B, Gerlach R, Gertzen E, Honegger J, Horstmann GA, Koch A, Kreitschmann-Andermahr I, Kunz M, Lagrèze WA, Nicolay NH, Paulus W, Reincke M, Schmidt MA, Weber MM, Wilhelm H, Fassnacht M (2021)
First German Guideline on Diagnostics and Therapy of Clinically Non-Functioning Pituitary Tumors.
Experimental and Clinical Endocrinolgy & Diabetes 2021 Mar; 129(3): 250-264
Zur Publikation

Dierks C, Seufert J, Aumann K, Ruf J, Klein C, Kiefer S, Rassner M, Boerries M, Zielke A, la Rosee P, Meyer PT, Kroiss M, Weißenberger C, Schumacher T, Metzger P, Weiss H, Smaxwil C, Laubner K, Duyster J, von Bubnoff N, Miething C, Thomusch O (2021)
Combination of Lenvatinib and Pembrolizumab Is an Effective Treatment Option for Anaplastic and Poorly Differentiated Thyroid Carcinoma.
Thyroid 2021 Jul; 31(7): 1076-1085
Zur Publikation

Elhassan YS, Altieri B, Berhane S, Cosentini D, Calabrese A, Haissaguerre M, Kastelan D, Fragoso MCBV, Bertherat J, Al Ghuzlan A, Haak H, Boudina M, Canu L, Loli P, Sherlock M, Kimpel O, Laganà M, Sitch AJ, Kroiss M, Arlt W, Terzolo M, Berruti A, Deeks JJ, Libé R, Fassnacht M, Ronchi CL (2021)
S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study.
European Journal of Endocrinology 2021 Nov 30; 186(1): 25-36
Zur Publikation

Giordano TJ, Berney D, de Krijger RR, Erickson L, Fassnacht M, Mete O, Papathomas T, Papotti M, Sasano H, Thompson LDR, Volante M, Gill AJ (2021)
Data set for reporting of carcinoma of the adrenal cortex: explanations and recommendations of the guidelines from the International Collaboration on Cancer Reporting.
Human Pathology 2021 Apr; 110: 50-61
Zur Publikation

Haider MS, Ahmad T, Groll J, Scherf-Clavel O, Kroiss M, Luxenhofer R (2021)
The Challenging Pharmacokinetics of Mitotane: An Old Drug in Need of New Packaging.
European Journal of Drug Metabolism and Pharmacokinetics 2021 Sep; 46(5): 575-593
Zur Publikation

Heinze B, Schirbel A, Nannen L, Michelmann D, Hartrampf PE, Bluemel C, Schneider M, Herrmann K, Haenscheid H, Fassnacht M, Buck AK, Hahner S (2021)
Novel CYP11B-ligand [123/131I]IMAZA as promising theranostic tool for adrenocortical tumors: comprehensive preclinical characterization and first clinical experience.
European Journal of Nuclear Medicine and Molecular Imaging 2021 Jul 21; 49(1): 301-310
Zur Publikation

Hendricks A, Lenschow C, Kroiss M, Buck A, Kickuth R, Germer CT, Schlegel N (2021)
Evaluation of diagnostic efficacy for localization of parathyroid adenoma in patients with primary hyperparathyroidism undergoing repeat surgery.
Langenbeck´s Archives of Surgery 2021 Aug; 406(5): 1615-1624
Zur Publikation

Horak P, Heining C, Kreutzfeldt S, Hutter B, Mock A, Hüllein J, Fröhlich M, Uhrig S, Jahn A, Rump A, Gieldon L, Möhrmann L, Hanf D, Teleanu V, Heilig CE, Lipka DB, Allgäuer M, Ruhnke L, Laßmann A, Endris V, Neumann O, Penzel R, Beck K, Richter D, Winter U, Wolf S, Pfütze K, Geörg C, Meißburger B, Buchhalter I, Augustin M, Aulitzky WE, Hohenberger P, Kroiss M, Schirmacher P, Schlenk RF, Keilholz U, Klauschen F, Folprecht G, Bauer S, Siveke JT, Brandts CH, Kindler T, Boerries M, Illert AL, von Bubnoff N, Jost PJ, Spiekermann K, Bitzer M, Schulze-Osthoff K, von Kalle C, Klink B, Brors B, Stenzinger A, Schröck E, Hübschmann D, Weichert W, Glimm H, Fröhling S (2021)
Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers.
Cancer Discovery 2021 Nov; 11(11): 2780-2795
Zur Publikation

Jaursch-Hancke C, Deutschbein T, Knappe UJ, Saeger W, Flitsch J, Fassnacht M (2021)
The Interdisciplinary Management of Newly Diagnosed Pituitary Tumors.
Deutsches Arzteblatt International 2021 Apr 9; 118(14): 237-243
Zur Publikation

Kimpel O, Bedrose S, Megerle F, Berruti A, Terzolo M, Kroiss M, Mai K, Dekkers OM, Habra MA, Fassnacht M (2021)
Adjuvant platinum-based chemotherapy in radically resected adrenocortical carcinoma: a cohort study.
British Journal of Cancer 2021 Oct; 125(9): 1233-1238
Zur Publikation

Koehler VF, Adam P, Frank-Raue K, Raue F, Berg E, Hoster E, Allelein S, Schott M, Kroiss M, Spitzweg C (2021)
Real-World Efficacy and Safety of Cabozantinib and Vandetanib in Advanced Medullary Thyroid Cancer.
Thyroid 2021 Mar; 31(3): 459-469
Zur Publikation

Koehler VF, Berg E, Adam P, Weber GL, Pfestroff A, Luster M, Kutsch JM, Lapa C, Sandner B, Rayes N, Fuss CT, Kreissl MC, Hoster E, Allelein S, Schott M, Todica A, Fassnacht M, Kroiss M, Spitzweg C (2021)
Real-World Efficacy and Safety of Multi-Tyrosine Kinase Inhibitors in Radioiodine Refractory Thyroid Cancer.
Thyroid 2021 Oct; 31(10): 1531-1541
Zur Publikation

Kolokotronis T, Reis H, Kroiss M (2021)
Multiple Hepatic and Pulmonary Tumors Combined with Bilateral Adrenal Masses in a Young Woman with von Hippel-Lindau Disease.
Gastroenterology 2021 Oct; 161(4): e1-e4
Zur Publikation

Landwehr LS, Schreiner J, Appenzeller S, Kircher S, Herterich S, Sbiera S, Fassnacht M, Kroiss M, Weigand I (2021)
A novel patient-derived cell line of adrenocortical carcinoma shows a pathogenic role of germline MUTYH mutation and high tumour mutational burden.
European Journal of Endocrinology 2021 May 4; 184(6): 823-835
Zur Publikation

Lenschow C, Fuss CT, Kircher S, Buck A, Kickuth R, Reibetanz J, Wiegering A, Stenzinger A, Hubschmann D, Germer CT, Fassnacht M, Frohling S, Schlegel N, Kroiss M (2021)
Case Report: Abdominal Lymph Node Metastases of Parathyroid Carcinoma: Diagnostic Workup, Molecular Diagnosis, and Clinical Management.
Frontiers in Endocrinology (Lausanne) 2021 Mar 23; 12: 643328
Zur Publikation

Loewe R, Rogowski-Lehmann N, Pfluger T, Reincke M, Hahner S, Bluemel C, Fassnacht M, Beuschlein F (2021)
Predicitve Value of FDG Uptake in the Remaining Adrenal Gland Following Adrenalectomy for Adrenocortical Cancer.
Hormone and Metabolic Research 2021 Jan; 53(1): 24-31
Zur Publikation

Losa M, Detomas M, Bailo M, Barzaghi LR, Albano L, Piloni M, Pagnano A, Pedone E, Mortini P (2021)
Gamma knife radiosurgery in patients with Nelson's syndrome.
Journal of Endocrinological Investigation 2021 Oct; 44(10): 2243-2251
Zur Publikation

Mai K, Fassnacht M, Führer-Sakel D, Honegger JB, Weber MM, Kroiss M (2021)
The Diagnosis and Management of Endocrine Side Effects of Immune Checkpoint Inhibitors.
Deutsches Arzteblatt International 2021 Jun 11; 118(Forthcoming):389-96
Zur Publikation

März J, Kurlbaum M, Roche-Lancaster O, Deutschbein T, Peitzsch M, Prehn C, Weismann D, Robledo M, Adamski J, Fassnacht M, Kunz M, Kroiss M (2021)
Plasma Metabolome Profiling for the Diagnosis of Catecholamine Producing Tumors.
Frontiers in Endocrinology (Lausanne)2021 Sep 7; 12: 722656
Zur Publikation

Murakami M, Sun N, Greunke C, Feuchtinger A, Kircher S, Deutschbein T, Papathomas T, Bechmann N, William Wallace P, Peitzsch M, Korpershoek E, Friemel J, Gimenez-Roqueplo AP, Robledo M, J L M Timmers H, Canu L, Weber A, R de Krijger R, Fassnacht M, Knösel T, Kirchner T, Reincke M, Karl Walch A, Kroiss M, Beuschlein F (2021)
Mass spectrometry imaging identifies metabolic patterns associated with malignant potential in pheochromocytoma and paraganglioma.
European Journal of Endocrinology 2021 Jun 5; 185(1): 179-191
Zur Publikation

Peitzsch M, Novos T, Kaden D, Kurlbaum M, van Herwaarden AE, Müller D, Adaway J, Grouzmann E, McWhinney B, Hoad K, Woollard G, Kema I, Boot C, Fassnacht M, Sweep F, Loh TP, Horvath AR, Eisenhofer G (2021)
Harmonization of LC-MS/MS Measurements of Plasma Free Normetanephrine, Metanephrine, and 3-Methoxytyramine.
Clinical Chemistry 2021 Aug 5; 67(8): 1098-1112
Zur Publikation

Sbiera I, Kircher S, Altieri B, Fassnacht M, Kroiss M, Sbiera S (2021)
Epithelial and Mesenchymal Markers in Adrenocortical Tissues: How Mesenchymal Are Adrenocortical Tissues?
Cancers (Basel) 2021 Apr 6; 13(7): 1736
Zur Publikation

Sbiera I, Kircher S, Altieri B, Lenz K, Hantel C, Fassnacht M, Sbiera S, Kroiss M (2021)
Role of FGF Receptors and Their Pathways in Adrenocortical Tumors and Possible Therapeutic Implications.
Frontiers in Endocrinology (Lausanne) 2021 Dec 9; 12: 795116
Zur Publikation

Schloetelburg W, Ebert I, Petritsch B, Weng AM, Dischinger U, Kircher S, Buck AK, Bley TA, Deutschbein T, Fassnacht M (2021)
Adrenal wash-out CT: moderate diagnostic value in distinguishing benign from malignant adrenal masses.
European Journal of Endocrinology 2021 Dec 10; 186(2): 183-193
Zur Publikation

Vogg N, Kurlbaum M, Deutschbein T, Gräsl B, Fassnacht M, Kroiss M (2021)
Method-Specific Cortisol and Dexamethasone Thresholds Increase Clinical Specificity of the Dexamethasone Suppression Test for Cushing Syndrome.
Clinical Chemistry 2021 Jul 6; 67(7): 998-1007
Zur Publikation

Weigand I, Ronchi CL, Vanselow JT, Bathon K, Lenz K, Herterich S, Schlosser A, Kroiss M, Fassnacht M, Calebiro D, Sbiera S (2021)
PKA Cα subunit mutation triggers caspase-dependent RIIβ subunit degradation via Ser114 phosphorylation.
Science Advances 2021 Feb 19; 7(8): eabd4176
Zur Publikation

Zimmermann S, Kurlbaum M, Mayer S, Fassnacht M, Kroiss M, Scherf-Clavel O (2021)
Simulation-Based Interpretation of Therapeutically Monitored Cabozantinib Plasma Concentration in Advanced Adrenocortical Carcinoma with Hemodialysis.
Therapeutic Drug Monitoring 2021 Oct 1; 43(5): 706-711
Zur Publikation

Altieri B, Ronchi CL, Kroiss M, Fassnacht M (2020)
Next-generation therapies for adrenocortical carcinoma.
Best Practice & Research Clinical Endocrinology & Metabolism 2020 May; 34 (3): 101434
Zur Publikation

Altieri B, Sbiera S, Herterich S, De Francia S, Della Casa S, Calabrese A, Pontecorvi A, Quinkler M, Kienitz T, Mannelli M, Canu L, Angelousi A, Chortis V, Kroiss M, Terzolo M, Fassnacht M, Ronchi CL (2020)
Effects of Germline CYP2W1*6 and CYP2B6*6 Single Nucleotide Polymorphisms on Mitotane Treatment in Adrenocortical Carcinoma: A Multicenter ENSAT Study.
Cancers (Basel) 2020 Feb 4; 12(2): E359
Zur Publikation

Bancos I, Taylor AE, Chortis V, Sitch AJ, Jenkinson C, Davidge-Pitts CJ, Lang K, Tsagarakis S, Macech M, Riester A, Deutschbein T, Pupovac ID, Kienitz T, Prete A, Papathomas TG, Gilligan LC, Bancos C, Reimondo G, Haissaguerre M, Marina L, Grytaas MA, Sajwani A, Langton K, Ivison HE, Shackleton CHL, Erickson D, Asia M, Palimeri S, Kondracka A, Spyroglou A, Ronchi CL, Simunov B, Delivanis DA, Sutcliffe RP, Tsirou I, Bednarczuk T, Reincke M, Burger-Stritt S, Feelders RA, Canu L, Haak HR, Eisenhofer G, Dennedy MC, Ueland GA, Ivovic M, Tabarin A, Terzolo M, Quinkler M, Kastelan D, Fassnacht M, Beuschlein F, Ambroziak U, Vassiliadi DA, O'Reilly MW, Young WF, Jr., Biehl M, Deeks JJ, Arlt W, Investigators EE-A (2020)
Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study.
The Lancet Diabetes & Endocrinology 2020; 8(9):773-781
Zur Publikation

Bechmann N, Moskopp ML, Ullrich M, Calsina B, Wallace PW, Richter S, Friedemann M, Langton K, Fliedner SMJ, Timmers H, Nolting S, Beuschlein F, Fassnacht M, Prejbisz A, Pacak K, Ghayee HK, Bornstein SR, Dieterich P, Pietzsch J, Wielockx B, Robledo M, Qin N, Eisenhofer G (2020)
HIF2alpha supports pro-metastatic behavior in pheochromocytomas/paragangliomas.
Endocrine-Related Cancer 2020  Nov; 27(11):625-640
Zur Publikation

Chifu I, Heinze B, Fuss CT, Lang K, Kroiss M, Kircher S, Ronchi CL, Altieri B, Schirbel A, Fassnacht M, Hahner S (2020)
Impact of the Chemokine Receptors CXCR4 and CXCR7 on Clinical Outcome in Adrenocortical Carcinoma.
Frontiers in Endocrinology (Lausanne) 2020 Nov 13; 11: 597878
Zur Publikation

Chortis V, Bancos I, Nijman T, Gilligan LC, Taylor AE, Ronchi CL, O'Reilly MW, Schreiner J, Asia M, Riester A, Perotti P, Libe R, Quinkler M, Canu L, Paiva I, Bugalho MJ, Kastelan D, Dennedy MC, Sherlock M, Ambroziak U, Vassiliadi D, Bertherat J, Beuschlein F, Fassnacht M, Deeks JJ, Biehl M, Arlt W (2020)
Urine Steroid Metabolomics as a Novel Tool for Detection of Recurrent Adrenocortical Carcinoma.
The Journal of Clinical Endocrinology & Metabolism 2020 Mar; 105(3): e307-e318
Zur Publikation

Creemers SG, Feelders RA, Valdes N, Ronchi CL, Volante M, van Hemel BM, Luconi M, Ettaieb MHT, Mannelli M, Chiara MD, Fassnacht M, Papotti M, Kerstens MN, Nesi G, Haak HR, van Kemenade FJ, Hofland LJ (2020)
The IGF2 methylation score for adrenocortical cancer: an ENSAT validation study.
Endocrine-Related Cancer 2020 Oct; 27(10): 541-550
Zur Publikation

Deutschbein T, Jaursch-Hancke C, Fassnacht M (2020)
[Non-functioning pituitary tumors – short presentation of the first German guideline].
Deutsche Medizinische Wochenschrift 2020 Oct; 145(20): 1444-1449
Zur Publikation

Di Dalmazi G, Altieri B, Scholz C, Sbiera S, Luconi M, Waldman J, Kastelan D, Ceccato F, Chiodini I, Arnaldi G, Riester A, Osswald A, Beuschlein F, Sauer S, Fassnacht M, Appenzeller S, Ronchi CL (2020)
RNA Sequencing and Somatic Mutation Status of Adrenocortical Tumors: Novel Pathogenetic Insights.
The Journal of Clinical Endocrinology & Metabolism 2020 Dec 1; 105(12): e4459-e4473
Zur Publikation

Doghman-Bouguerra M, Finetti P, Durand N, Parise IZS, Sbiera S, Cantini G, Canu L, Hescot S, Figueiredo MMO, Komechen H, Sbiera I, Nesi G, Paci A, Al Ghuzlan A, Birnbaum D, Baudin E, Luconi M, Fassnacht M, Figueiredo BC, Bertucci F, Lalli E (2020)
Cancer-testis Antigen FATE1 Expression in Adrenocortical Tumors Is Associated with A Pervasive Autoimmune Response and Is A Marker of Malignancy in Adult, but Not Children, ACC.
Cancers (Basel) 2020  Mar 14; 12(3): 689 
Zur Publikation

Eisenhofer G, Deutschbein T, Constantinescu G, Langton K, Pamporaki C, Calsina B, Monteagudo M, Peitzsch M, Fliedner S, Timmers H, Bechmann N, Fankhauser M, Nolting S, Beuschlein F, Stell A, Fassnacht M, Prejbisz A, Lenders JWM, Robledo M (2020)
Plasma metanephrines and prospective prediction of tumor location, size and mutation type in patients with pheochromocytoma and paraganglioma.
Clinical Chemistry and Laboratory Medicine 2020 Oct 1; 59(2): 353-363
Zur Publikation

Elbelt U, Schlaffer SM, Buchfelder M, Knappe UJ, Vila G, Micko A, Deutschbein T, Unger N, Lammert A, Topuzoglu-Muller T, Bojunga J, Droste M, Johanssen S, Kolenda H, Ritzel K, Buslei R, Strasburger CJ, Petersenn S, Honegger J (2020)
Efficacy of Temozolomide Therapy in Patients With Aggressive Pituitary Adenomas and Carcinomas-A German Survey.
The Journal of Clinical Endocrinology & Metabolism 2020 Mar 1; 105(3): dgz 211
Zur Publikation 

Fassnacht M, Assie G, Baudin E, Eisenhofer G, de la Fouchardiere C, Haak HR, de Krijger R, Porpiglia F, Terzolo M, Berruti A, clinicalguidelines@esmo.org EGCEa (2020)
Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Annals of Oncology 2020 Nov; 31(11): 1476-1490
Zur Publikation

Haider MS, Schreiner J, Kendl S, Kroiss M, Luxenhofer R (2020)
A Micellar Mitotane Formulation with High Drug-Loading and Solubility: Physico-Chemical Characterization and Cytotoxicity Studies in 2D and 3D In Vitro Tumor Models.
Macromolecular Bioscience 2020 Jan; 20(1): e1900178
Zur Publikation

Jiang J, Zhang J, Pang Y, Bechmann N, Li M, Monteagudo M, Calsina B, Gimenez-Roqueplo AP, Nolting S, Beuschlein F, Fassnacht M, Deutschbein T, Timmers H, Akerstrom T, Crona J, Quinkler M, Fliedner SMJ, Liu Y, Guo J, Li X, Guo W, Hou Y, Wang C, Zhang L, Xiao Q, Liu L, Gao X, Burnichon N, Robledo M, Eisenhofer G (2020)
Sino-European Differences in the Genetic Landscape and Clinical Presentation of Pheochromocytoma and Paraganglioma.
The Journal of Clinical Endocrinology & Metabolism 2020 Oct 1; 105(10):dgaa502
Zur Publikation

Jouinot A, Lippert J, Fassnacht M, de La Villeon B, Septier A, Neou M, Perlemoine K, Appenzeller S, Sibony M, Gaujoux S, Dousset B, Libe R, Groussin L, Ronchi CL, Assie G, Bertherat J (2020)
Intratumor heterogeneity of prognostic DNA-based molecular markers in adrenocortical carcinoma.
Endocrine Connections 2020 Jul; 9(7):705-714
Zur Publikation

Kroiss M, Megerle F, Kurlbaum M, Zimmermann S, Wendler J, Jimenez C, Lapa C, Quinkler M, Scherf-Clavel O, Habra MA, Fassnacht M (2020)
Objective Response and Prolonged Disease Control of Advanced Adrenocortical Carcinoma with Cabozantinib.
The Journal of Clinical Endocrinology & Metabolism 2020 May 1; 105(5): 1461-1468
Zur Publikation

Kroiss M, Schilling B, Deutschbein T (2020)
[Endocrine side effects of cancer immunotherapy].
Deutsche Medizinische Wochenschrift 2020 Dec; 145(24): 1736-1741
Zur Publikation

Kurlbaum M, Sbiera S, Kendl S, Martin Fassnacht M, Kroiss M (2020)
Steroidogenesis in the NCI-H295 Cell Line Model is Strongly Affected By Culture Conditions and Substrain.
Experimental and Clinical Endocrinology & Diabetes 2020 May 12; 128(10): 672-680
Zur Publikation

Lacombe AMF, Soares IC, Mariani BMP, Nishi MY, Bezerra-Neto JE, Charchar HDS, Brondani VB, Tanno F, Srougi V, Chambo JL, Costa de Freitas RM, Mendonca BB, Hoff AO, Almeida MQ, Weigand I, Kroiss M, Zerbini MCN, Fragoso M (2020)
Sterol O-Acyl Transferase 1 as a Prognostic Marker of Adrenocortical Carcinoma.
Cancers (Basel) 2020 Jan; 12(1): 247
Zur Publikation

Landwehr LS, Altieri B, Schreiner J, Sbiera I, Weigand I, Kroiss M, Fassnacht M, Sbiera S (2020)
Interplay between glucocorticoids and tumor-infiltrating lymphocytes on the prognosis of adrenocortical carcinoma.
Journal for ImmunoTherapy of Cancer 2020 May; 8(1): e000469
Zur Publikation

Lenders JWM, Kerstens MN, Amar L, Prejbisz A, Robledo M, Taieb D, Pacak K, Crona J, Zelinka T, Mannelli M, Deutschbein T, Timmers H, Castinetti F, Dralle H, Widimsky J, Gimenez-Roqueplo AP, Eisenhofer G (2020)
Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension.
Journal of Hypertension 2020 Aug; 38(9): 1443-1456
Zur Publikation

Lenschow C, Schragle S, Kircher S, Lorenz K, Machens A, Dralle H, Riss P, Scheuba C, Pfestroff A, Spitzweg C, Zielke A, Niessen A, Dotzenrath C, Riemann B, Quinkler M, Vorlander C, Zahn A, Raue F, Chiapponi C, Iwen KA, Steinmuller T, Kroiss M, Schlegel N, group Ns (2020)
Clinical Presentation, Treatment, and Outcome of Parathyroid Carcinoma: Results of the NEKAR Retrospective International Multicenter Study.
Annals of Surgery 2020
Zur Publikation

Liang R, Weigand I, Lippert J, Kircher S, Altieri B, Steinhauer S, Hantel C, Rost S, Rosenwald A, Kroiss M, Fassnacht M, Sbiera S, Ronchi CL (2020)
Targeted Gene Expression Profile Reveals CDK4 as Therapeutic Target for Selected Patients With Adrenocortical Carcinoma.
Frontiers in Endocrinology (Lausanne) 2020 Apr 16; 11(20): 219
Zur Publikation

Majidi F, Martino S, Kondakci M, Antke C, Haase M, Chortis V, Arlt W, Ronchi CL, Fassnacht M, Laurent C, Petit JM, Casasnovas O, Habra AM, Kanji A, Salvatori R, Ho ATN, Spyroglou A, Beuschlein F, Villa D, Limvorapitak W, Wahlin BE, Gimm O, Rudelius M, Schott M, Germing U, Haas R, Gattermann N (2020)
Clinical spectrum of primary adrenal lymphoma: results of a multicenter cohort study.
European Journal of Endocrinology 2020 Oct; 183(4): 453-462
Zur Publikation

Oreglia M, Sbiera S, Fassnacht M, Guyon L, Denis J, Cristante J, Chabre O, Cherradi N (2020)
Early Postoperative Circulating miR-483-5p Is a Prognosis Marker for Adrenocortical Cancer.
Cancers (Basel) 2020 Mar 12; 12(3): 724
Zur Publikation

Rai SK, Bril F, Hatch HM, Xu Y, Shelton L, Kalavalapalli S, Click A, Lee D, Beecher C, Kirby A, Kong K, Trevino J, Jha A, Jatav S, Kriti K, Luthra S, Garrett TJ, Guingab-Cagmat J, Plant D, Bose P, Cusi K, Hromas RA, Tischler AS, Powers JF, Gupta P, Bibb J, Beuschlein F, Robledo M, Calsina B, Timmers H, Taieb D, Kroiss M, Richter S, Langton K, Eisenhofer G, Bergeron R, Jr., Pacak K, Tevosian SG, Ghayee HK (2020)
Targeting pheochromocytoma/paraganglioma with polyamine inhibitors.
Metabolism 2020 Jun 17; 110: 154297
Zur Publikation

Smith DC, Kroiss M, Kebebew E, Habra MA, Chugh R, Schneider BJ, Fassnacht M, Jafarinasabian P, Ijzerman MM, Lin VH, Mohideen P, Naing A (2020)
A phase 1 study of nevanimibe HCl, a novel adrenal-specific sterol O-acyltransferase 1 (SOAT1) inhibitor, in adrenocortical carcinoma.
Investigational New Drugs 2020 Oct; 38(5): 1421-1429
Zur Publikation

Vogel T, Wendler J, Frank-Raue K, Kreissl MC, Spitzweg C, Fassnacht M, Raue F, Kroiss M (2020)
Bone Metastases in Medullary Thyroid Carcinoma: High Morbidity and Poor Prognosis Associated With Osteolytic Morphology.
The Journal of Clinical Endocrinology & Metabolism 2020 Jun 1; 105(6): dgaa077
Zur Publikation

Voronina N, Wong JKL, Hubschmann D, Hlevnjak M, Uhrig S, Heilig CE, Horak P, Kreutzfeldt S, Mock A, Stenzinger A, Hutter B, Frohlich M, Brors B, Jahn A, Klink B, Gieldon L, Sieverling L, Feuerbach L, Chudasama P, Beck K, Kroiss M, Heining C, Mohrmann L, Fischer A, Schrock E, Glimm H, Zapatka M, Lichter P, Frohling S, Ernst A (2020)
The landscape of chromothripsis across adult cancer types.
Nature Communications 2020 May 8; 11(1): 2320
Zur Publikation

Wallace PW, Conrad C, Bruckmann S, Pang Y, Caleiras E, Murakami M, Korpershoek E, Zhuang Z, Rapizzi E, Kroiss M, Gudziol V, Timmers HJ, Mannelli M, Pietzsch J, Beuschlein F, Pacak K, Robledo M, Klink B, Peitzsch M, Gill AJ, Tischler AS, de Krijger RR, Papathomas T, Aust D, Eisenhofer G, Richter S (2020)
Metabolomics, machine learning and immunohistochemistry to predict succinate dehydrogenase mutational status in phaeochromocytomas and paragangliomas.
Journal of Pathology 2020 May 27; 251(4): 378-387
Zur Publikation

Weigand I, Altieri B, Lacombe AMF, Basile V, Kircher S, Landwehr LS, Schreiner J, Zerbini MCN, Ronchi CL, Megerle F, Berruti A, Canu L, Volante M, Paiva I, Della Casa S, Sbiera S, Fassnacht M, Fragoso M, Terzolo M, Kroiss M (2020)
Expression of SOAT1 in Adrenocortical Carcinoma and Response to Mitotane Monotherapy: An ENSAT Multicenter Study.
The Journal of Clinical Endocrinology & Metabolism 2020 Aug 20; 105(8): 2642-2653
Zur Publikation

Weigand I, Schreiner J, Rohrig F, Sun N, Landwehr LS, Urlaub H, Kendl S, Kiseljak-Vassiliades K, Wierman ME, Angeli JPF, Walch A, Sbiera S, Fassnacht M, Kroiss M (2020)
Active steroid hormone synthesis renders adrenocortical cells highly susceptible to type II ferroptosis induction.
Cell Death & Disease 2020 Mar 17; 11(3): 192
Zur Publikation

Werner RA, Bundschuh RA, Bundschuh L, Lapa C, Yin Y, Javadi MS, Buck AK, Higuchi T, Pienta KJ, Pomper MG, Lodge MA, Gorin MA, Rowe SP (2020)
Semiquantitative Parameters in PSMA-Targeted PET Imaging with [(18)F]DCFPyL: Impact of Tumor Burden on Normal Organ Uptake.
Molecular Imaging and Biology 2020 Feb 1; 22(1): 190-197
Zur Publikation

Wirth LJ, Sherman E, Robinson B, Solomon B, Kang H, Lorch J, Worden F, Brose M, Patel J, Leboulleux S, Godbert Y, Barlesi F, Morris JC, Owonikoko TK, Tan DSW, Gautschi O, Weiss J, de la Fouchardiere C, Burkard ME, Laskin J, Taylor MH, Kroiss M, Medioni J, Goldman JW, Bauer TM, Levy B, Zhu VW, Lakhani N, Moreno V, Ebata K, Nguyen M, Heirich D, Zhu EY, Huang X, Yang L, Kherani J, Rothenberg SM, Drilon A, Subbiah V, Shah MH, Cabanillas ME (2020)
Efficacy of Selpercatinib in RET-Altered Thyroid Cancers
The New English Journal of Medicine 2020 Aug 27; 383(9): 825-835
Zur Publikation

An Y, Reimann M, Masjkur J, Langton K, Peitzsch M, Deutschbein T, Fassnacht M, Rogowski-Lehmann N, Beuschlein F, Fliedner S, Stell A, Prejbisz A, Januszewicz A, Lenders J, Bornstein SR, Eisenhofer G (2019)
Adrenomedullary function, obesity and permissive influences of catecholamines on body mass in patients with chromaffin cell tumours.
International Journal of Obesity (London) 2019; 43(2): 263-275
Zur Publikation

Assié G, Jouinot A, Fassnacht M, Libé R, Garinet S, Jacob L, Hamzaoui N, Neou M, Sakat J, de La Villéon B, Perlemoine K, Ragazzon B, Sibony M, Tissier F, Gaujoux S, Dousset B, Sbiera S, Ronchi CL, Kroiss M, Korpershoek E, De Krijger R, Waldmann J, Quinkler M, Haissaguerre M, Tabarin A, Chabre O, Luconi M, Mannelli M, Groussin L, Bertagna X, Baudin E, Amar L, Coste J, Beuschlein F, Bertherat J (2019)
Value of Molecular Classification for Prognostic Assessment of Adrenocortical Carcinoma.
JAMA Oncology 2019 Jul 11; 5(10): 1440-1447
Zur Publikation 

Bathon K, Weigand I, Vanselow JT, Ronchi CL, Sbiera S, Schlosser A, Fassnacht M, Calebiro D (2019)
Alterations in Protein Kinase A Substrate Specificity as a Potential Cause of Cushing's Syndrome.
Endocrinology 2019 Feb; 160(2): 447-459
Zur Publikation

Belavgeni A, Bornstein SR, von Mässenhausen A, Tonnus W, Stumpf J, Meyer C, Othmar E, Latk M, Kanczkowski W, Kroiss M, Hantel C, Hugo C, Fassnacht M, Ziegler CG, Schally AV, Krone NP, Linkermann A (2019)
Exquisite sensitivity of adrenocortical carcinomas to induction of ferroptosis.
Proceeding National Academy Science (PNAS) USA 2019 Oct 14; 116(44): 22269-22274
Zur Publikation

Canu L, Van Hemert JAW, Kerstens M, Hartman RP, Khanna A, Kraljevic I, Kastelan D, Badiu C, Ambroziak U, Tabarin A, Haissaguerre M, Buitenwerf E, Visser A, Mannelli M, Arlt W, Chortis V, Bourdeau I, Gagnon N, Buchy M, Borson-Chazot F, Deutschbein T, Fassnacht M, Hubalewska Dydejczyk HA, Motyka M, Rzepka E, Casey RT, Challis BG, Quinkler M, Vroonen L, Spyroglou A, Beuschlein F, Lamas C, Young WF, Bancos I, Timmers HJLM (2019)
CT characteristics of pheochromocytoma - Relevance for the evaluation of adrenal incidentaloma.
The Journal of Clinical Endocrinology & Metabolism 2019 Feb; 104(2): 312-318
Zur Publikation

Chortis V, Bancos I, Nijman T, Gilligan LC, Taylor AE, Ronchi CL, O'Reilly MW, Schreiner J, Asia M, Riester A, Perotti P, Libé R, Quinkler M, Canu L, Paiva I, Bugalho MJ, Kastelan D, Dennedy MC, Sherlock M, Ambroziak U, Vassiliadi D, Bertherat J, Beuschlein F, Fassnacht M, Deeks JJ, Biehl M, Arlt W (2019)
Urine steroid metabolomics as a novel tool for detection of recurrent adrenocortical carcinoma.
The Journal of Clinical Endocrinology & Metabolism 2019 Oct 29; 105(3): e307-e318
Zur Publikation 

Erlic Z, Kurlbaum M, Deutschbein T, Nölting S, Prejbisz A, Timmers HJ, Richter S, Prehn C, Weismann D, Adamski J, Januszewicz A, Reincke M, Fassnacht M, Robledo M, Eisenhofer G, Beuschlein F, Kroiss M. 2019 Metabolic impact of pheochromocytoma/paraganglioma (2019)
Targeted metabolomics in patients before and after tumor removal.
European Journal of Endocrinology 2019 Oct 1; 181(6): 647-657
Zur Publikation

Fankhauser M, Bechmann N, Lauseker M, Goncalves J, Favier J, Klink B, William D, Gieldon L, Maurer J, Spöttl G, Rank P, Knösel T, Orth M, Ziegler CG, Aristizabal Prada ET, Rubinstein G, Fassnacht M, Spitzweg C, Grossman AB, Pacak K, Beuschlein F, Bornstein SR, Eisenhofer G, Auernhammer CJ, Reincke M, Nölting S (2019)
Synergistic Highly Potent Targeted Drug Combinations in different Pheochromocytoma Models including Human Tumor Cultures.
Endocrinology 2019 Jul 19; 160(11): 2600-2617
Zur Publikation

Farahati J, Mäder U, Gilman E, Görges R, Maric I, Binse I, Hänscheid H, Herrmann K, Buck A, Bockisch A (2019)
Changing trends of incidence and prognosis of thyroid carcinoma.
Nuklearmedizin 2019 Mar; 58(2): 86-92
Zur Publikation

Friedl B, Kurlbaum M, Kroiss M, Fassnacht M, Scherf-Clavel O (2019)
A method for the minimally invasive drug monitoring of mitotane by means of volumetric absorptive microsampling for a home-based therapeutic drug monitoring.
Analytical and Bioanalytical Chemistry 2019 Jul; 411(17): 3951-3962
Zur Publikation

Geroula A, Deutschbein T, Langton K, Masjkur JR, Pamporaki C, Peitzsch M, Fliedner S, Timmers HJ, Bornstein SR, Beuschlein F, Stell A, Januszewicz A, Prejbisz A, Fassnacht M, Lenders J, Eisenhofer G (2019)
Pheochromocytoma and paraganglioma: Clinical feature based disease probability in relation to catecholamine biochemistry and reason for disease suspicion.
Eurorpean Journal of Endocrinology 2019 Aug 1; 181(4): 409-420
Zur Publikation

Hescot S, Curras-Freixes M, Deutschbein T, van Berkel A, Vezzosi D, Amar L, de la Fouchardière C, Valdes N, Riccardi N, Do Cao C, Bertherat J, Goichot B, Beuschlein F, Drui D, Canu L, Niccoli P, Laboureau S, Tabarin A, Leboulleux S, Calsina B, Libé R, Faggiano A, Schlumberger M, Borson-Chazot F, Mannelli M, Gimenez-Roqueplo AP, Caron P, Timmers HJLM, Fassnacht M, Robledo M, Borget I, Baudin E (2019)
European Network for the Study of Adrenal Tumors (ENS@T). Prognosis of malignant pheochromocytoma and paraganglioma (MAPP-Prono study): an ENS@T retrospective study.
The Journal of Clinical Endocrinology & Metabolism 2019 Jun; 104(6): 2367-2374
Zur Publikation

Kroiss M, Deutschbein T, Schlötelburg W, Ronchi CL, Hescot S, Körbl D, Megerle F, Beuschlein F, Neu B, Quinkler M, Baudin E, Hahner S, Heidemeier A, Fassnacht M (2019)
Treatment of Refractory Adrenocortical Carcinoma with Thalidomide: Analysis of 27 Patients from the European Network for the Study of Adrenal Tumours Registry.
Experimental and Clinical Endocrinology & Diabetes 2019 Oct; 127(9): 578-584
Zur Publikation

Rao D, van Berkel A, Piscaer I, Young WF, Gruber L, Deutschbein T, Fassnacht M, Beuschlein F, Spyroglou A, Prejbisz A, Hanus K, Eisenhofer G, Manelli M, Canu L, Lenders JWM, Bancos I, Timmers HJLM (2019)
Impact of 123 I-MIBG scintigraphy on clinical decision making in pheochromocytoma and paraganglioma.
The Journal of Clinical Endocrinology & Metabolism 2019 Mar 1; 104(9): 3812-3820
Zur Publikation

Reibetanz J, Rinn B, Kunz AS, Flemming S, Ronchi CL, Kroiss M, Deutschbein T, Pulzer A, Hahner S, Kocot A, Germer CT, Fassnacht M, Jurowich C (2019)
Patterns of Lymph Node Recurrence in Adrenocortical Carcinoma: Possible Implications for Primary Surgical Treatment.
Annales of Surgical Oncology 2019; 26(2): 531-538
Zur Publikation

Sbiera S, Perez-Rivas LG, Taranets L, Weigand I, Flitsch J, Graf E, Monoranu CM, Saeger W, Hagel C, Honegger J, Assie G, Hermus AR, Stalla GK, Herterich S, Ronchi CL, Deutschbein T, Reincke M, Strom TM, Popov N, Theodoropoulou M, Fassnacht M (2019)
Driver mutations in USP8 wild type Cushing’s disease.
Neuro-Oncology 2019 Oct; 21(10): 1273-1283
Zur Publikation

Sbiera S, Kendl S, Weigand I, Sbiera I, Fassnacht M, Kroiss M (2019)
Hsp90 inhibition in adrenocortical carcinoma: Limited drug synergism with mitotane.
Molecular and  Cellular Endocrinology 2019 Jan 15; 480: 36-41
Zur Publikation

Sbiera S, Kunz M, Weigand I, Deutschbein T, Dandekar T, Fassnacht M (2019)
The New Genetic Landscape of Cushing's Disease: Deubiquitinases in the Spotlight.
Cancers (Basel) 2019 Nov 8; 11(11): 1761
Zur Publikation

Schweitzer S, Kunz M, Kurlbaum M, Vey J, Kendl S, Deutschbein T, Hahner S, Fassnacht M, Dandekar T, Kroiss M (2019)
Plasma steroid metabolome profiling for the diagnosis of adrenocortical carcinoma.
European Journal of Endocrinology 2019 Feb; 180(2): 117-12
Zur Publikation

Siebert C, Ciato D, Murakami M, Frei-Stuber L, Perez-Rivas LG, Monteserin-Garcia JL, Nölting S, Maurer J, Feuchtinger A, Walch AK, Haak HR, Bertherat J, Mannelli M, Fassnacht M, Korpershoek E, Reincke M, Stalla GK, Hantel C, Beuschlein F (2019)
Heat Shock Protein 90 as a Prognostic Marker and Therapeutic Target for Adrenocortical Carcinoma.
Frontiers in Endocrinology 2019 Jul19; 10: 487
Zur Publikation

Sun N, Kunzke T, Sbiera S, Kircher S, Feuchtinger A, Aichler M, Herterich S, Ronchi CL, Weigand I, Schlegel N, Waldmann J, Candida Villares Fragoso M, Whitsett TG, Gill AJ, Fassnacht M, Walch A, Kroiss M (2019)
Prognostic Relevance of Steroid Sulfation in Adrenocortical Carcinoma Revealed by Molecular Phenotyping Using High-Resolution Mass Spectrometry Imaging.
Clinical Chemistry 2019 Oct 1; 65(10): 1276-1286
Zur Publikation

Weigand I, Knobloch L, Flitsch J, Saeger W, Monoranu CM, Höfner K, Herterich S, Rotermund R, Ronchi CL, Buchfelder M, Glatzel M, Hagel C, Fassnacht M, Deutschbein T, Sbiera S (2019)
Impact of USP8 gene mutations on protein deregulation in Cushing's disease.
The Journal of Clinical Endocrinology & Metabolism 2019 Mar 7; 104(7): 2535–2546
Zur Publikation

Werner RA, Hänscheid H, Leal JP, Javadi MS, Higuchi T, Lodge MA, Buck AK, Pomper MG, Lapa C, Rowe SP (2019)
Impact of Tumor Burden on Quantitative [68Ga] DOTATOC Biodistribution.
Molecular Imaging and Biology 2019 Aug 1; 21(4): 790-798
Zur Publikation

Werner RA, Bundschuh RA, Higuchi T, Javadi MS, Rowe SP, Zsótér N, Kroiss M, Fassnacht M, Buck AK, Kreissl MC, Lapa C (2019)
Volumetric and texture analysis of pretherapeutic 18F-FDG PET can predict overall survival in medullary thyroid cancer patients treated with Vandetanib.
Endocrine 2019; 63(2): 293-300
Zur Publikation